195 related articles for article (PubMed ID: 11923421)
1. Localization of activator protein-1 complex with DNA binding activity in mitochondria of murine brain after in vivo treatment with kainate.
Ogita K; Okuda H; Kitano M; Fujinami Y; Ozaki K; Yoneda Y
J Neurosci; 2002 Apr; 22(7):2561-70. PubMed ID: 11923421
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor activator protein-1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in murine hippocampus.
Ogita K; Fujinami Y; Kitano M; Yoneda Y
J Neurosci Res; 2003 Sep; 73(6):794-802. PubMed ID: 12949905
[TBL] [Abstract][Full Text] [Related]
3. Predominant expression of nuclear activator protein-1 complex with DNA binding activity following systemic administration of N-methyl-D-aspartate in dentate granule cells of murine hippocampus.
Yoneda Y; Ogita K; Azuma Y; Kuramoto N; Manabe T; Kitayama T
Neuroscience; 1999; 93(1):19-31. PubMed ID: 10430467
[TBL] [Abstract][Full Text] [Related]
4. Sustained potentiation of AP1 DNA binding is not always associated with neuronal death following systemic administration of kainic acid in murine hippocampus.
Kitayama T; Ogita K; Yoneda Y
Neurochem Int; 1999 Dec; 35(6):453-62. PubMed ID: 10524713
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and phosphorylation of particular fos family members by kainate in nuclear and cytosolic fractions of murine hippocampus.
Manabe T; Kitayama T; Ogita K; Yoneda Y
Neuroscience; 2000; 100(3):453-63. PubMed ID: 11098108
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate signaling to nuclear activator protein-1 through mechanisms different from those for kainate signaling in murine brain.
Yoneda Y; Ogita K; Azuma Y; Ikeda M; Tagami H; Manabe T
Neuroscience; 1999 May; 90(2):519-33. PubMed ID: 10215156
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone attenuates kainate-induced AP-1 activation in rat brain.
Unlap T; Jope RS
Brain Res Mol Brain Res; 1994 Jul; 24(1-4):275-82. PubMed ID: 7968367
[TBL] [Abstract][Full Text] [Related]
8. Enhanced binding activity of nuclear antioxidant-response element through possible formation of Nrf2/Fos-B complex after in vivo treatment with kainate in murine hippocampus.
Ogita K; Kubo M; Nishiyama N; Watanabe M; Nagashima R; Yoneda Y
Neuropharmacology; 2004 Mar; 46(4):580-9. PubMed ID: 14975682
[TBL] [Abstract][Full Text] [Related]
9. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment.
Pennypacker KR; Thai L; Hong JS; McMillian MK
J Neurosci; 1994 Jul; 14(7):3998-4006. PubMed ID: 8027758
[TBL] [Abstract][Full Text] [Related]
10. Nuclear degradation of particular Fos family members expressed following injections of NMDA and kainate in murine hippocampus.
Nakamichi N; Manabe T; Yoneda Y
Neurochem Res; 2002 Feb; 27(1-2):131-8. PubMed ID: 11926265
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of cytoplasmic activator protein-1 with DNA binding activity and responsiveness to ionotropic glutamate signals in the murine hippocampus.
Azuma Y; Ogita K; Yoneda Y
Neuroscience; 1999; 92(4):1295-308. PubMed ID: 10426485
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death.
Kaminska B; Filipkowski RK; Zurkowska G; Lason W; Przewlocki R; Kaczmarek L
Eur J Neurosci; 1994 Oct; 6(10):1558-66. PubMed ID: 7850019
[TBL] [Abstract][Full Text] [Related]
13. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus.
Ogita K; Okuda H; Watanabe M; Nagashima R; Sugiyama C; Yoneda Y
Neuropharmacology; 2005 May; 48(6):810-21. PubMed ID: 15829253
[TBL] [Abstract][Full Text] [Related]
14. In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons.
Ogita K; Okuda H; Yamamoto Y; Nishiyama N; Yoneda Y
J Neurochem; 2003 Jun; 85(5):1336-46. PubMed ID: 12753091
[TBL] [Abstract][Full Text] [Related]
15. Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids.
Unlap T; Jope RS
Brain Res Mol Brain Res; 1995 Feb; 28(2):193-200. PubMed ID: 7723618
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of kainate-induced gene expression in rat hippocampus.
Pennypacker KR; McMillian MK; Douglass J; Hong JS
J Neurochem; 1994 Feb; 62(2):438-44. PubMed ID: 8294905
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats.
Pérez J; Vezzani A; Civenni G; Tutka P; Rizzi M; Schüpbach E; Hoyer D
Neuroscience; 1995 Apr; 65(4):1087-97. PubMed ID: 7617164
[TBL] [Abstract][Full Text] [Related]
18. Kainate-induced changes in opioid peptide genes and AP-1 protein expression in the rat hippocampus.
Pennypacker KR; Walczak D; Thai L; Fannin R; Mason E; Douglass J; Hong JS
J Neurochem; 1993 Jan; 60(1):204-11. PubMed ID: 8417141
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
20. Changes in glutamate receptors, c-fos mRNA expression and activator protein-1 (AP-1) DNA binding activity in the brain of phenobarbital-dependent and -withdrawn rats.
Tanaka S; Kiuchi Y; Numazawa S; Oguchi K; Yoshida T; Kuroiwa Y
Brain Res; 1997 May; 756(1-2):35-45. PubMed ID: 9187311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
